CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday

  • Raymond James raised CSX Corporation CSX price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close at $27.54 on Friday.
  • Keybanc cut the price target on Match Group, Inc. MTCH from $82 to $74. Keybanc analyst Justin Patterson maintained an Overweight rating on the stock. Match Group shares fell 0.5% to $42.77 in pre-market trading.
  • BMO Capital lowered Green Plains Inc. GPRE price target from $45 to $31. BMO Capital analyst Kenneth Zaslow downgraded the stock from Outperform to Market Perform. Green Plains shares rose 5.2% to close at $29.02 on Friday.
  • Piper Sandler cut NovoCure Limited NVCR price target from $90 to $70. Piper Sandler analyst Jason Bednar downgraded the stock from Overweight to Neutral. NovoCure fell 1.5% to $71.55 in pre-market trading.
  • Barclays cut Analog Devices, Inc. ADI price target from $180 to $140. Barclays analyst Blayne Curtis downgraded the stock from Overweight to Equal-Weight. Analog Devices shares fell 1.6% to $144.29 in pre-market trading.
  • HC Wainwright & Co cut Talaris Therapeutics, Inc. TALS price target from $18 to $12. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Talaris Therapeutics shares fell 2.8% to $1.38 in pre-market trading.

Check out this: This Analyst With 90% Accuracy Rate Slashes PT On Snap; Here Are 5 Stock Picks For Last Week From Benzinga's Most Accurate Analysts

Price Target
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading IdeasPrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!